Table 1 Means and (SD) of patients’ characteristics at baseline
From: Fampridine and quality of life in individuals with multiple sclerosis
Patients’ characteristics | All patients (n = 50) | Non-respondent (n = 35) | Respondent (n = 15) | p |
|---|---|---|---|---|
Age (years) | 51.4 (11.7) | 49.2 (10.9) | 55.5 (12.3) | 0.06 |
Gender (m/f %) | 32/68 | 30/70 | 35/65 | 0.45 |
EDSS | 5.2 (1.1) | 5 (1.0) | 5.8 (1.1) | 0.01 |
Height (m) | 1.67 (0.09) | 1.67 (0.09) | 1.66 (0.08) | 0.66 |
Body mass (kg) | 75.5 (17.2) | 73.1 (16.9) | 80.12 (17.4) | 0.17 |
BMI (kg m−2) | 27 (5.7) | 26 (5.7) | 28.9 (5.5) | 0.09 |
Disease duration (years) | 14.3 (9.3) | 13.5 (8.5) | 16.2 (11) | 0.36 |
MS type (RR–SP–PP %) | 22–48–32 | 22–49–29 | 13–47–40 | 0.22 |